Fred Hardwicke

522 total citations
36 papers, 377 citations indexed

About

Fred Hardwicke is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Fred Hardwicke has authored 36 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Hematology. Recurrent topics in Fred Hardwicke's work include Cancer Treatment and Pharmacology (12 papers), Advanced Breast Cancer Therapies (7 papers) and Multiple Myeloma Research and Treatments (6 papers). Fred Hardwicke is often cited by papers focused on Cancer Treatment and Pharmacology (12 papers), Advanced Breast Cancer Therapies (7 papers) and Multiple Myeloma Research and Treatments (6 papers). Fred Hardwicke collaborates with scholars based in United States, United Kingdom and Ireland. Fred Hardwicke's co-authors include Everardo Cobos, Kenneth Nugent, Alejandro Perez‐Verdia, Nicholas D’Cunha, Yuefei Yu, Maurizio Chiriva‐Internati, W. Martin Kast, Martin J. Cannon, Somedeb Ball and Leonardo Mirandola and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Fred Hardwicke

32 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fred Hardwicke United States 9 222 119 69 60 56 36 377
Marjan Ertault France 9 88 0.4× 52 0.4× 43 0.6× 39 0.7× 63 1.1× 14 306
Hiroto Horiguchi Japan 9 124 0.6× 61 0.5× 99 1.4× 59 1.0× 70 1.3× 29 336
Masato Moriyama Japan 10 46 0.2× 36 0.3× 61 0.9× 67 1.1× 75 1.3× 35 298
Josef Kovařík United Kingdom 10 169 0.8× 40 0.3× 62 0.9× 139 2.3× 37 0.7× 42 449
Chul-Won Jung South Korea 7 414 1.9× 53 0.4× 30 0.4× 32 0.5× 26 0.5× 15 563
Pauline Laly France 8 350 1.6× 26 0.2× 75 1.1× 75 1.3× 12 0.2× 16 460
Jennifer Wu Taiwan 8 338 1.5× 154 1.3× 104 1.5× 61 1.0× 20 0.4× 17 639
Xiaowei Xu United States 6 263 1.2× 258 2.2× 66 1.0× 44 0.7× 107 1.9× 6 611
Walid Shalata Israel 11 224 1.0× 30 0.3× 48 0.7× 141 2.4× 6 0.1× 62 388
Mark Appleton United Kingdom 13 109 0.5× 197 1.7× 78 1.1× 69 1.1× 18 0.3× 17 479

Countries citing papers authored by Fred Hardwicke

Since Specialization
Citations

This map shows the geographic impact of Fred Hardwicke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Hardwicke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Hardwicke more than expected).

Fields of papers citing papers by Fred Hardwicke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred Hardwicke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Hardwicke. The network helps show where Fred Hardwicke may publish in the future.

Co-authorship network of co-authors of Fred Hardwicke

This figure shows the co-authorship network connecting the top 25 collaborators of Fred Hardwicke. A scholar is included among the top collaborators of Fred Hardwicke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred Hardwicke. Fred Hardwicke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Thein, Kyaw Zin, Nusrat Jahan, Ahmed Sultan, et al.. (2019). MA03.07 First-Line Atezolizumab Chemoimmunotherapy in Advanced Non-Squamous NSCLC Patients Harboring EGFR/ALK Genetic Alterations. Journal of Thoracic Oncology. 14(10). S259–S259.
5.
Ball, Somedeb, Avash Das, Wasawat Vutthikraivit, et al.. (2019). Risk of Infection Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Clinical Lymphoma Myeloma & Leukemia. 20(2). 87–97.e5. 23 indexed citations
6.
7.
Quick, Donald P., Somedeb Ball, Fred Hardwicke, et al.. (2019). Incidence of Second Primary Malignancies and Peripheral Sensory Neuropathy in Patients with Multiple Myeloma Receiving Daratumumab Containing Regimen. Blood. 134(Supplement_1). 5550–5550. 3 indexed citations
8.
Ismail, Amr, Ahmed Sultan, Kyaw Zin Thein, et al.. (2018). P3.CR-03 Pulmonary Spindle Cell Neoplasm - Neoadjuvant Treatment and Response. Journal of Thoracic Oncology. 13(10). S1030–S1030.
9.
Perisetti, Abhilash, Benjamin Tharian, Irfan Warraich, et al.. (2018). Pure Squamous Cell Carcinoma of the Gallbladder Masquerading as a Hepatic Mass. Cureus. 10(1). e2011–e2011. 8 indexed citations
10.
11.
Verma, Rashmi, et al.. (2015). Treatment of Hepatic Epithelioid Hemangioendothelioma: Finding Uses for Thalidomide in a New Era of Medicine. SHILAP Revista de lepidopterología. 2015. 1–4. 25 indexed citations
12.
Panikkath, Ragesh, Venu Madhav Konala, Deepa Panikkath, Elvira Umyarova, & Fred Hardwicke. (2014). FatalClostridium SepticumInfection in a Patient with a Hematological Malignancy. Baylor University Medical Center Proceedings. 27(2). 111–112. 3 indexed citations
13.
Radhi, Saba, Raed Alalawi, Leonardo Mirandola, et al.. (2012). Novel tumor markers in non-small cell lung cancer detected both in serology and tissue.. Journal of Clinical Oncology. 30(15_suppl). e21105–e21105. 2 indexed citations
14.
Chiriva‐Internati, Maurizio, Yuefei Yu, Leonardo Mirandola, et al.. (2011). Identification of AKAP‐4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer. The Prostate. 72(1). 12–23. 40 indexed citations
15.
Chiriva‐Internati, Maurizio, Raffaele Ferrari, Yuefei Yu, et al.. (2008). The pituitary tumor transforming gene 1 (PTTG-1): An immunological target for multiple myeloma. Journal of Translational Medicine. 6(1). 15–15. 14 indexed citations
16.
Ferrari, Raffaele, Yifan Yu, Juan Carlos Alvarez Moreno, et al.. (2008). AKAP-4 as biomarker for prostate cancer. 56(1). 394–394.
17.
Perez‐Verdia, Alejandro, et al.. (2005). Acute Cardiac Toxicity Associated with High‐Dose Intravenous Methotrexate Therapy: Case Report and Review of the Literature. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(9). 1271–1276. 43 indexed citations
18.
Gunn, G. Brandon, et al.. (2004). Nasopharyngeal Carcinoma Metastasis to the Pituitary Gland: A Case Report and Literature Review. Journal of Neuro-Oncology. 68(1). 87–90. 8 indexed citations
19.
Hardwicke, Fred, et al.. (2003). A review of clinical experience with paclitaxel extravasations. Supportive Care in Cancer. 11(5). 270–277. 24 indexed citations
20.
Hardwicke, Fred, et al.. (2003). Non-Hodgkin's lymphoma occurring as pure central nervous system pathology.. PubMed. 1(9). 554–5; discussion 555. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marjan Ertault Breakdown of academic impact, for papers by Hiroto Horiguchi Breakdown of academic impact, for papers by Masato Moriyama Breakdown of academic impact, for papers by Josef Kovařík Breakdown of academic impact, for papers by Chul-Won Jung Breakdown of academic impact, for papers by Pauline Laly Breakdown of academic impact, for papers by Jennifer Wu Breakdown of academic impact, for papers by Xiaowei Xu Breakdown of academic impact, for papers by Walid Shalata Breakdown of academic impact, for papers by Mark Appleton
Rankless by CCL
2026